At meeting held on 06 December 2017
The Board of Directors of Wintac at its meeting held on 06 December 2017 have decided to exercise the borrowing option in the form of ECB up to Rs 40 crore from the holding company, Veego Pharma LLC, USA to fund new capital expenditure (building additional capacities for Opthalmic and Injectable Vials). The Board has decided to defer the rights issue proposal temporarilyPowered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)